Fast acting haemostat:
Creates a robust gel plug sealing the bleed site
Works independent of classic clotting pathway
Safe and clinical effective supported by a range of peer reviewed published clinical papers
With over 17 years of leading the way in global management of haemostasis using CELOXTM technology across trauma, emergency services and military applications, we are passionate about extending the application of this innovative solution to create a unique approach to help solve the global challenge posed by PPH.
CELOX PPH provides Rapid and Effective Control of Uterine Postpartum bleeding
Fast Acting – Unique mode of action reducing the need for further intervention
Safe & Clinically Effective – 10 years of clinical efficacy vs standard of care
Versatile & Easy to Use – Allowing globalisation of the technology in Developed and Developing Nations
“CELOX PPH is highly effective in the control and treatment of uterine PPH”
“CELOX PPH achieved a success rate of 95.6% haemostasis for grade 1 to 3 bleeding (vaginal deliveries)”
“CELOX PPH achieves haemostasis and avoids further surgical therapy”
“CELOX PPH achieved a success rate of 100% haemostasis for grade 1 & 2 bleeding (up to 2500mls)”
“The use of CELOX PPH results in a reduction in hysterectomy rates of up to 78%”
“Can be used with patients on anticoagulant therapy or trauma induced coagulopathy”
“CELOX PPH is highly effective in the control and treatment of uterine PPH”
“CELOX PPH achieved a success rate of 95.6% haemostasis for grade 1 to 3 bleeding (vaginal deliveries)”
“CELOX PPH achieves haemostasis and avoids further surgical therapy”
“CELOX PPH achieved a success rate of 100% haemostasis for grade 1 & 2 bleeding (up to 2500mls)”
“The use of CELOX PPH results in a reduction in hysterectomy rates of up to 78%”
“Can be used with patients on anticoagulant therapy or trauma induced coagulopathy”
